Takeda reiterates the need of equitable access to healthcare for universal impact
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The product is expected to start contributing meaningfully to the revenue from FY25
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Subscribe To Our Newsletter & Stay Updated